Business Context and Reporting Period
This Form 8-K is a current report filed by ReWalk Robotics Ltd. (noted as Lifeward Ltd. in request metadata) on August 4, 2016. The filing serves to announce the company's financial results for the second quarter ended June 30, 2016. The report references a press release (Exhibit 99.1) containing the detailed results and announces a conference call held on the filing date to discuss these results.
Key Financial Metrics
The provided text is a cover document and does not contain specific numerical data. Consequently, the following metrics are not available in this filing text:
- Revenue: Not provided.
- Profit/Loss: Not provided.
- Cash Flow: Not provided.
- Margins: Not provided.
- Debt and Liquidity: Not provided.
Investors must refer to the attached press release (Exhibit 99.1) for specific financial figures.
Material Changes
The filing text does not disclose specific material changes in financial performance or operations compared to prior periods. It solely confirms the issuance of the Q2 2016 results announcement.
Guidance, Outlook, and Risks
Management Commentary: Management scheduled a conference call on August 4, 2016, at 8:30 AM EDT to discuss the second-quarter results. Details on how to access the live webcast and archived recording are provided.
Legal Disclaimer: The filing explicitly states that the information contained in this Form 8-K and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed "incorporated by reference" into any other filings, except as expressly set forth by specific reference.
Guidance and Risks: No specific forward-looking guidance, risk factors, or contingencies are detailed in this cover document.
Key Facts for Investor Verification
- Verify the specific revenue, net loss, and cash burn figures in the attached Exhibit 99.1 (Press Release), as they are absent from this summary text.
- Confirm the company's cash runway and liquidity position based on the Q2 2016 data.
- Review the conference call transcript (if available) for management's commentary on the commercialization of the ReWalk exoskeleton and regulatory updates.
- Note the legal distinction that this 8-K text itself is not "filed" under Section 18 of the 1934 Act, limiting its liability status compared to standard 10-Q or 10-K filings.